Quality assurance in radiotherapy

被引：19
作者：
Kouloulias, VE [1 ]
机构：
[1] European Org Res Treatment Canc, Ctr Data, B-1200 Brussels, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2003年 / 39卷 / 04期
关键词：
EORTC; quality assurance; radiotherapy;
D O I：
10.1016/S0959-8049(02)00461-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In 1999, the European Organisation for Research and Treatment of Cancer (EORTC), being a European pioneer in the field of cancer research as well as in quality assurance (QA), launched an Emmanuel van der Schueren fellowship for QA in radiotherapy. In this paper, the work that has been done during the first E. van der Schucren fellowship is reported, focusing on four phase III EORTC clinical trials: 22921 for rectal cancer, 22961 and 22991 for prostate cancer and 22922 for breast cancer. A historical review of the QA programme of the EORTC Radiotherapy group during the past 20 years is included. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：415 / 422
页数：8
相关论文
共 45 条
[1]   HIGH-DOSE HIGH-PRECISION RADIOTHERAPY - A CONSENSUS MEETING ON THE OCCASION OF THE 10TH ANNIVERSARY OF THE INITIATION OF THE QUALITY-ASSURANCE-PROGRAM OF THE EORTC-RADIOTHERAPY-COOPERATIVE-GROUP HELD ON 15 AND 16 JANUARY 1993 HOTEL-BEAU-RIVAGE, 13 QUAI DU MONT-BLANC, 1201 GENEVA, SWITZERLAND - FOREWORD [J].
BARTELINK, H ;
BERNIER, J ;
KURTZ, J ;
GARAVAGLIA, G .
RADIOTHERAPY AND ONCOLOGY, 1993, 29 (02) :R11-R12
[2]   QUALITY ASSURANCE IN CONSERVATIVE TREATMENT OF EARLY BREAST-CANCER - REPORT ON A CONSENSUS MEETING OF THE EORTC RADIOTHERAPY AND BREAST-CANCER COOPERATIVE GROUPS AND THE EUSOMA (EUROPEAN-SOCIETY-OF-MASTOLOGY) [J].
BARTELINK, H ;
GARAVAGLIA, G ;
JOHANSSON, KA ;
MIJNHEER, BJ ;
VANDENBOGAERT, W ;
VANTIENHOVEN, G ;
YARNOLD, J .
RADIOTHERAPY AND ONCOLOGY, 1991, 22 (04) :323-326
[3]   Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer [J].
Bentzen, SM ;
Bernier, J ;
Davis, JB ;
Horiot, JC ;
Garavaglia, G ;
Chavaudra, J ;
Johansson, KA ;
Bolla, M .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) :615-620
[4]   Profile of radiotherapy departments contributing to the cooperative group of radiotherapy of the European organization for research and treatment of cancer [J].
Bernier, J ;
Horiot, JC ;
Bartelink, H ;
Johansson, KA ;
Cionini, L ;
Gonzalez, DG ;
Hamers, H ;
vandenBogaert, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (04) :953-960
[5]   EORTC GUIDELINES FOR WRITING PROTOCOLS FOR CLINICAL-TRIALS OF RADIOTHERAPY [J].
BOLLA, M ;
BARTELINK, H ;
GARAVAGLIA, G ;
GONZALEZ, D ;
HORIOT, JC ;
JOHANSSON, KA ;
VANTIENHOVEN, G ;
VANTONGELEN, K ;
VANGLABBEKE, M .
RADIOTHERAPY AND ONCOLOGY, 1995, 36 (01) :1-8
[6]  
BOLLA M, 2000, 22991 EORTC PROTOCOL
[7]  
BOLLA M, 1997, 22961 EORTC DAT CTR
[8]  
Bosset J F, 1998, Cancer Radiother, V2, P703, DOI 10.1016/S1278-3218(99)80011-0
[9]  
Bosset JF, 1996, ANN CHIR, V50, P302
[10]   Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial [J].
Bosset, JF ;
Magnin, V ;
Maingon, P ;
Mantion, G ;
Pelissier, EP ;
Mercier, M ;
Chaillard, G ;
Horiot, JC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (02) :323-327
12345